Dr. Katherine Lemming is a pharmacist who is specialized in Pediatrics in Houston, Texas. Patients can reach her at 6621 Fannin St, Houston or contact her on 832-826-0000. Active license number of Dr. Katherine Lemming is 0202215092 for Pediatrics in Virginia. Dr. Katherine Lemming is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists that ensures the safe and effective use of medications for all children from neonates through adolescents.
Complete Profile:
Dr. Katherine Lemming speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Katherine Lemming
Specialization:
Pediatrics
Credentials:
PHARM.D.
Gender:
Female
Location:
6621 Fannin St, Houston, Texas, 77030-2358
Phone:
832-826-0000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Katherine Lemming are as mentioned below.
NPI Number:
1376992305
NPI Enumeration Date:
09 Jun, 2016
NPI Last Update On:
07 Jun, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Katherine Lemming are as mentioned below.
Specialization
License Number
State
Status
Pediatrics
0202215092
Virginia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6621 Fannin St, Houston, Texas
Zip:
77030-2358
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Katherine Lemming at 6621 Fannin St, Houston, Texas or can call on phone at 832-826-0000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.